期刊
RSC ADVANCES
卷 6, 期 59, 页码 54564-54572出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c6ra10407j
关键词
-
资金
- National Natural Science Foundation of China [21275088, 81373373, 21435002]
In this work, a multi-type cell microfluidic integrator for cocultivation and enabling simulation of drug absorption, metabolism, and anticancer activity was developed. To organize an in vitro drug absorption and metabolism model, Caco-2, HepG2, and U251 cells were co-cultured as mimics of the intestine, liver, and glioblastoma, respectively. The HepG2 cell channel was separated from the Caco-2 cell channel by a polycarbonate semipermeable membrane, and connected with the U251 cell channel by a narrow channel array. Microfluidic cell co-culture, irinotecan (CPT-11) metabolism and cytotoxic analysis were performed simultaneously on the chip. This mimic organ-to-organ network carried out long-distance drug transfer under a microflow environment. The drug cytotoxicity assay was monitored by fluorescence visualization. The extra-/intra-cellular CPT-11 and its active metabolite of 7-ethyl-10-hydroxycamptothecin (SN-38) were qualitatively and quantitatively characterized by liquid chromatography-tandem mass spectrometry. It was revealed that prodrug CPT-11 was absorbed by Caco-2 cells and transferred to HepG2 cells through the porous membrane, then CPT-11 transformed to active SN-38 by HepG2 cells. Metabolic SN-38 was pumped out of HepG2 cells and diffused from the HepG2 cell channel toward the U251 cell channel through a connection channel array to targeting U251 cells. Our results suggest that this dynamic 3D device provides a potential application for high throughput drug screening and personalized cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据